1 |
DeMauro SB, Duncan AF, Hurt H. Telemedicine use in neonatal follow-up programs - What can we do and what we can't - Lessons learned from COVID-19. Semin Perinatol 2021;45:151430.
DOI
|
2 |
Ma XL, Chen Z, Zhu JJ, Shen XX, Wu MY, Shi LP, et al. Management strategies of neonatal jaundice during the coronavirus disease 2019 outbreak. World J Pediatr 2020;16:247-50.
DOI
|
3 |
Taylor JA, Stout JW, De Greef L, Geol M, Patel S, Jung EK, et al. Use of a smartphone app to assess neonatal jaundice. Pediatrics 2017;140:e20170312.
DOI
|
4 |
Rong ZH, Luo F, Ma LY, Chen L, Wu L, Liu W, et al. Evaluation of an automatic image-based screening technique for neonatal hyperbilirubinemia. Zhonghua Er Ke Za Zhi 2016;54:597-600.
|
5 |
Chua BS, Song LH, Chang CT, Lim XJ, Nachiappan J. Drive-through transcutaneous bilirubin screening for neonatal jaundice: a safe and efficient system during the COVID-19 pandemic. J Paediatr Child Health 2021;57:12-4.
DOI
|
6 |
Pettersson M, Eriksson M, Albinsson E, Ohlin A. Home phototherapy for hyperbilirubinemia in term neonates-an unblinded multicentre randomized controlled trial. Eur J Pediatr 2021;180:1603-10.
DOI
|
7 |
Outlaw F, Nixon M, Odeyemi O, MacDonald LW, Meek J, Leung TS. Smartphone screening for neonatal jaundice via ambient-subtracted sclera chromaticity. PLoS One 2020;15:e0216970.
DOI
|
8 |
Chu L, Qiao J, Xu C. Home-based phototherapy versus hospital-based phototherapy for treatment of neonatal hyperbilirubinemia: a systematic review and meta-analysis. Clin Pediatr 2020;59:588-95.
DOI
|